Douglas Mental Health University Institute
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1881-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.douglas.qc.ca
Clinical Trials
41
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (34 trials with phase data)• Click on a phase to view related trials
Daridorexant for Alzheimer Disease Prevention
- Conditions
- Alzheimer Disease (AD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-10-08
- Last Posted Date
- 2025-10-08
- Lead Sponsor
- Douglas Mental Health University Institute
- Target Recruit Count
- 240
- Registration Number
- NCT07213349
- Locations
- 🇨🇦
Centre StoP-Alzheimer (Douglas Mental Health University Institute - Research Centre), Montreal, Quebec, Canada
Spatial Memory Training and Cognitive Function
- Conditions
- Mild Cognitive Impairment
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- Douglas Mental Health University Institute
- Target Recruit Count
- 80
- Registration Number
- NCT07002996
- Locations
- 🇨🇦
Douglas Mental Health University Institute, Verdun, Quebec, Canada
Predicting Psychotic Relapse Using Speech-Based Early Detection
- Conditions
- Psychosis
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Douglas Mental Health University Institute
- Target Recruit Count
- 250
- Registration Number
- NCT06978894
- Locations
- 🇨🇦
Robarts Research Institute, London, Ontario, Canada
🇨🇦Douglas Mental Health University Institute, Montreal, Quebec, Canada
🇨🇦Vitam, Quebec, Canada
Magnetoencephalography in Psychosis Program
- Conditions
- Schizophrenia DisordersPsychosis
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Douglas Mental Health University Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06978881
- Locations
- 🇨🇦
Douglas Mental Health University Institute, Montreal, Quebec, Canada
HYEEG Discourse in Psychosis: A Neurobehavioural Study
- Conditions
- PsychosisSchizophrenia Disorders
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Douglas Mental Health University Institute
- Target Recruit Count
- 110
- Registration Number
- NCT06978803
- Locations
- 🇨🇦
Douglas Mental Health University Institute, Montreal, Quebec, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
